Jesus Delgado-Calle
Concepts (178)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 16 | 2022 | 205 | 5.580 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 65 | 4.020 |
Why?
| Bone Resorption | 9 | 2022 | 300 | 2.690 |
Why?
| Bone and Bones | 10 | 2021 | 512 | 2.650 |
Why?
| Receptors, Notch | 3 | 2022 | 34 | 2.430 |
Why?
| Osteoclasts | 7 | 2021 | 443 | 2.400 |
Why?
| Osteogenesis | 10 | 2022 | 387 | 2.280 |
Why?
| Parathyroid Hormone | 5 | 2022 | 220 | 2.270 |
Why?
| Osteoblasts | 9 | 2017 | 539 | 1.800 |
Why?
| Bone Remodeling | 5 | 2021 | 178 | 1.750 |
Why?
| Multiple Myeloma | 7 | 2022 | 2686 | 1.750 |
Why?
| Signal Transduction | 11 | 2022 | 1801 | 1.700 |
Why?
| DNA Methylation | 10 | 2016 | 572 | 1.580 |
Why?
| RANK Ligand | 6 | 2018 | 178 | 1.580 |
Why?
| Bone Diseases | 3 | 2021 | 105 | 1.580 |
Why?
| Cell Communication | 3 | 2022 | 72 | 1.560 |
Why?
| Genetic Markers | 9 | 2020 | 121 | 1.350 |
Why?
| Osteolysis | 3 | 2022 | 79 | 1.310 |
Why?
| Adaptor Proteins, Signal Transducing | 11 | 2020 | 209 | 1.280 |
Why?
| Bone Marrow Cells | 4 | 2021 | 250 | 1.260 |
Why?
| Osteoporosis | 5 | 2016 | 185 | 1.230 |
Why?
| Bone Neoplasms | 2 | 2017 | 194 | 1.170 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 3 | 2022 | 32 | 1.070 |
Why?
| Epigenesis, Genetic | 5 | 2016 | 384 | 0.980 |
Why?
| Azacitidine | 5 | 2016 | 38 | 0.950 |
Why?
| Animals | 19 | 2022 | 14247 | 0.810 |
Why?
| Osteoporotic Fractures | 3 | 2014 | 14 | 0.790 |
Why?
| Gene Deletion | 2 | 2017 | 278 | 0.770 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 6 | 0.730 |
Why?
| Down-Regulation | 3 | 2016 | 396 | 0.720 |
Why?
| Hip Fractures | 3 | 2014 | 68 | 0.720 |
Why?
| Adipogenesis | 3 | 2017 | 56 | 0.720 |
Why?
| Mice | 14 | 2022 | 6232 | 0.720 |
Why?
| Bone Marrow | 2 | 2020 | 408 | 0.710 |
Why?
| Adipocytes | 2 | 2019 | 148 | 0.660 |
Why?
| Gene Expression Regulation | 3 | 2014 | 1117 | 0.650 |
Why?
| Osteoarthritis, Hip | 2 | 2013 | 31 | 0.630 |
Why?
| Osteoprotegerin | 3 | 2016 | 53 | 0.630 |
Why?
| Cellular Microenvironment | 1 | 2016 | 27 | 0.620 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 86 | 0.580 |
Why?
| Humans | 32 | 2022 | 50276 | 0.560 |
Why?
| Cell Line | 6 | 2020 | 1205 | 0.540 |
Why?
| Cell Line, Tumor | 5 | 2021 | 1472 | 0.540 |
Why?
| Stress, Mechanical | 1 | 2013 | 94 | 0.520 |
Why?
| Disease Progression | 3 | 2021 | 867 | 0.500 |
Why?
| Nitric Oxide | 1 | 2013 | 282 | 0.450 |
Why?
| Cell Lineage | 1 | 2011 | 99 | 0.450 |
Why?
| Alkaline Phosphatase | 1 | 2011 | 100 | 0.440 |
Why?
| Fractures, Bone | 1 | 2012 | 118 | 0.440 |
Why?
| Mice, Knockout | 4 | 2018 | 980 | 0.440 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 209 | 0.410 |
Why?
| CpG Islands | 4 | 2016 | 106 | 0.380 |
Why?
| Neoplasms | 1 | 2017 | 1143 | 0.360 |
Why?
| Fibroblast Growth Factors | 2 | 2020 | 60 | 0.330 |
Why?
| Disease Models, Animal | 4 | 2021 | 1638 | 0.310 |
Why?
| Cell Differentiation | 6 | 2021 | 750 | 0.310 |
Why?
| Glycoproteins | 2 | 2016 | 135 | 0.310 |
Why?
| Mice, Inbred C57BL | 3 | 2022 | 2022 | 0.300 |
Why?
| Weight-Bearing | 2 | 2016 | 65 | 0.280 |
Why?
| Aged, 80 and over | 7 | 2016 | 3496 | 0.280 |
Why?
| Clodronic Acid | 1 | 2021 | 20 | 0.230 |
Why?
| X-Ray Microtomography | 1 | 2021 | 63 | 0.230 |
Why?
| Hyperostosis | 1 | 2020 | 2 | 0.220 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 206 | 0.220 |
Why?
| Female | 11 | 2022 | 27910 | 0.220 |
Why?
| Intercellular Signaling Peptides and Proteins | 3 | 2016 | 133 | 0.220 |
Why?
| Transcription, Genetic | 2 | 2013 | 442 | 0.220 |
Why?
| Bone Density Conservation Agents | 1 | 2021 | 82 | 0.220 |
Why?
| Osteitis Deformans | 1 | 2020 | 2 | 0.210 |
Why?
| Molecular Sequence Data | 2 | 2013 | 970 | 0.210 |
Why?
| Neoplasm Invasiveness | 1 | 2021 | 294 | 0.210 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2020 | 220 | 0.200 |
Why?
| Aging | 2 | 2016 | 740 | 0.200 |
Why?
| Neovascularization, Pathologic | 1 | 2020 | 172 | 0.200 |
Why?
| Insulin-Like Growth Factor I | 1 | 2020 | 148 | 0.200 |
Why?
| Cells, Cultured | 4 | 2018 | 1787 | 0.190 |
Why?
| Aged | 8 | 2016 | 10017 | 0.190 |
Why?
| Coculture Techniques | 1 | 2019 | 161 | 0.190 |
Why?
| beta Catenin | 2 | 2015 | 98 | 0.170 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1082 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 1 | 2021 | 1550 | 0.170 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 116 | 0.170 |
Why?
| 5-Methylcytosine | 1 | 2016 | 14 | 0.170 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 134 | 0.160 |
Why?
| Extracellular Matrix Proteins | 1 | 2016 | 77 | 0.160 |
Why?
| Gene Expression | 3 | 2020 | 701 | 0.160 |
Why?
| Neoplasm Metastasis | 1 | 2017 | 258 | 0.160 |
Why?
| Lipids | 1 | 2017 | 160 | 0.160 |
Why?
| Organ Size | 1 | 2016 | 259 | 0.160 |
Why?
| Calcification, Physiologic | 2 | 2016 | 42 | 0.150 |
Why?
| Stromal Cells | 2 | 2019 | 98 | 0.150 |
Why?
| Sequence Analysis, DNA | 2 | 2014 | 260 | 0.150 |
Why?
| Cell Proliferation | 3 | 2016 | 1117 | 0.150 |
Why?
| Dexamethasone | 1 | 2017 | 398 | 0.140 |
Why?
| Cell Survival | 1 | 2017 | 680 | 0.140 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2014 | 26 | 0.140 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 477 | 0.140 |
Why?
| Pulsatile Flow | 1 | 2013 | 17 | 0.140 |
Why?
| Culture Media, Conditioned | 1 | 2013 | 50 | 0.140 |
Why?
| Glucocorticoids | 1 | 2016 | 271 | 0.130 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2016 | 422 | 0.130 |
Why?
| DNA Modification Methylases | 1 | 2013 | 33 | 0.130 |
Why?
| Stem Cells | 1 | 2014 | 195 | 0.130 |
Why?
| Hallux Valgus | 1 | 2012 | 4 | 0.130 |
Why?
| Promoter Regions, Genetic | 2 | 2014 | 534 | 0.130 |
Why?
| Transfection | 1 | 2013 | 424 | 0.130 |
Why?
| Up-Regulation | 1 | 2014 | 519 | 0.120 |
Why?
| Models, Biological | 1 | 2016 | 842 | 0.120 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 534 | 0.120 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 217 | 0.120 |
Why?
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2011 | 1 | 0.120 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2012 | 54 | 0.120 |
Why?
| Sequence Deletion | 1 | 2012 | 85 | 0.120 |
Why?
| Cloning, Molecular | 1 | 2012 | 205 | 0.120 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2011 | 38 | 0.120 |
Why?
| Genome-Wide Association Study | 1 | 2013 | 191 | 0.120 |
Why?
| Laser Capture Microdissection | 1 | 2011 | 6 | 0.120 |
Why?
| Calibration | 1 | 2011 | 56 | 0.110 |
Why?
| HEK293 Cells | 1 | 2012 | 249 | 0.110 |
Why?
| Cell Count | 1 | 2011 | 192 | 0.110 |
Why?
| Blood Proteins | 1 | 2011 | 100 | 0.110 |
Why?
| Cytokines | 1 | 2014 | 671 | 0.110 |
Why?
| DNA | 1 | 2014 | 563 | 0.110 |
Why?
| Receptors, Glucocorticoid | 1 | 2010 | 45 | 0.110 |
Why?
| Transcription Factor AP-1 | 1 | 2010 | 71 | 0.110 |
Why?
| MicroRNAs | 1 | 2014 | 358 | 0.110 |
Why?
| Mice, Transgenic | 3 | 2020 | 724 | 0.100 |
Why?
| Nuclear Proteins | 1 | 2012 | 269 | 0.100 |
Why?
| Base Sequence | 1 | 2011 | 719 | 0.100 |
Why?
| Protein Binding | 1 | 2012 | 756 | 0.100 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 532 | 0.100 |
Why?
| Apoptosis | 1 | 2016 | 1313 | 0.100 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1244 | 0.090 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 57 | 0.090 |
Why?
| Proteins | 1 | 2011 | 388 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2011 | 1129 | 0.090 |
Why?
| Breast Neoplasms | 1 | 2017 | 1200 | 0.090 |
Why?
| Tissue Scaffolds | 2 | 2019 | 36 | 0.090 |
Why?
| Cohort Studies | 1 | 2011 | 1444 | 0.080 |
Why?
| Primary Cell Culture | 2 | 2019 | 65 | 0.080 |
Why?
| Male | 5 | 2014 | 27231 | 0.080 |
Why?
| Chromatin | 2 | 2016 | 140 | 0.070 |
Why?
| Middle Aged | 3 | 2016 | 13149 | 0.070 |
Why?
| Bone Density | 2 | 2015 | 427 | 0.060 |
Why?
| Nucleocapsid Proteins | 1 | 2020 | 1 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2020 | 137 | 0.050 |
Why?
| Bombyx | 1 | 2019 | 1 | 0.050 |
Why?
| Tissue Engineering | 1 | 2019 | 65 | 0.050 |
Why?
| Phenotype | 1 | 2020 | 801 | 0.040 |
Why?
| Cyclin D1 | 1 | 2016 | 61 | 0.040 |
Why?
| Osteocalcin | 1 | 2016 | 46 | 0.040 |
Why?
| Calcitriol | 1 | 2016 | 48 | 0.040 |
Why?
| Child, Preschool | 2 | 2016 | 3972 | 0.040 |
Why?
| Genome, Human | 1 | 2016 | 127 | 0.040 |
Why?
| Mice, Nude | 1 | 2016 | 270 | 0.040 |
Why?
| Young Adult | 2 | 2016 | 4120 | 0.040 |
Why?
| Twins, Monozygotic | 1 | 2014 | 17 | 0.040 |
Why?
| Microarray Analysis | 1 | 2014 | 83 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2014 | 55 | 0.040 |
Why?
| Genomics | 1 | 2016 | 246 | 0.030 |
Why?
| Immunoblotting | 1 | 2014 | 132 | 0.030 |
Why?
| Osteosarcoma | 1 | 2014 | 43 | 0.030 |
Why?
| Gene Frequency | 1 | 2013 | 118 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 163 | 0.030 |
Why?
| Adolescent | 2 | 2016 | 6596 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2014 | 178 | 0.030 |
Why?
| Bone Lengthening | 1 | 2012 | 5 | 0.030 |
Why?
| Child | 2 | 2016 | 6482 | 0.030 |
Why?
| Histones | 1 | 2014 | 325 | 0.030 |
Why?
| Transcriptome | 1 | 2014 | 327 | 0.030 |
Why?
| Orthopedic Procedures | 1 | 2012 | 101 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 544 | 0.030 |
Why?
| Quality of Life | 1 | 2014 | 728 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 55 | 0.020 |
Why?
| RNA Interference | 1 | 2008 | 201 | 0.020 |
Why?
| Flow Cytometry | 1 | 2010 | 581 | 0.020 |
Why?
| Cell Movement | 1 | 2008 | 300 | 0.020 |
Why?
| Adult | 1 | 2016 | 13861 | 0.010 |
Why?
|
|
Delgado-Calle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|